Papers
2
Total Citations
110
H-Index
2
About
Bing Han is a clinician-researcher whose work spans two cutting-edge domains of minimally invasive and robotic medicine: surgical oncology and cardiac electrophysiology. Han's most significant contribution to date is a landmark 2024 multicentre randomised controlled trial comparing robotic versus open pancreaticoduodenectomy for pancreatic head and periampullary tumours — one of the most technically demanding procedures in abdominal surgery. This rigorously designed study has already garnered 100 citations within its first year of publication, signalling its immediate and substantial influence on how surgeons approach complex pancreatic resections globally. By generating high-level evidence around robotic surgical outcomes, including postoperative length of stay and complication rates, Han's research directly informs clinical decision-making and surgical training standards. Beyond oncology, Han has also investigated the neurological safety of cardiac ablation technologies, exploring whether robotic magnetic navigation during atrial fibrillation ablation can reduce the incidence of silent cerebral embolism — a subtle but clinically meaningful complication. Together, these contributions establish Han as a researcher committed to leveraging robotic technology to improve patient safety, refine surgical technique, and produce rigorous evidence across multiple high-stakes clinical specialties.
Research Focus
Key Achievements
Top Papers
- 1
- 2